You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ACZ885

Showing 1 - 25 of 71
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cigarette Smoking-Related Carcinoma, Lung Carcinoma Trial in Columbus (procedure, biological, other)

Not yet recruiting
  • Cigarette Smoking-Related Carcinoma
  • Lung Carcinoma
  • Biospecimen Collection
  • +4 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Sep 6, 2023

Pulmonary Sarcoidosis Trial in Germany, Netherlands, United States (ACZ885, Placebo)

Completed
Has Results
  • Pulmonary Sarcoidosis
  • ACZ885
  • Placebo
  • Birmingham, Alabama
  • +7 more
Sep 30, 2021

Pancreatic Cancer Trial in New York (Canakinumab, Tislelizumab, Nab-Paclitaxel)

Recruiting
  • Pancreatic Cancer
  • New York, New York
  • +2 more
Aug 2, 2023

Polymyalgia Rheumatica, Inflammatory Diseases Trial in Worldwide (AIN457, ACZ885, Prednisone)

Terminated
Has Results
  • Polymyalgia Rheumatica
  • Inflammatory Diseases
  • Rochester, Minnesota
  • +5 more
Aug 17, 2021

Clonal Cytopenia of Undetermined Significance Trial in Columbus (procedure, drug, other)

Recruiting
  • Clonal Cytopenia of Undetermined Significance
  • Biospecimen Collection
  • +6 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Dec 12, 2022

Adult Onset Still's Disease Trial in Japan (Canakinumab)

Recruiting
  • Adult Onset Still's Disease
  • Canakinumab
  • Nagoya, Aichi, Japan
  • +15 more
Jul 14, 2022

Carcinoma, Renal Cell Trial in New York (Spartalizumab, Canakinumab)

Recruiting
  • Carcinoma, Renal Cell
  • New York, New York
    Columbia University Medical Center
May 6, 2022

Sickle Cell Anemia Trial in Worldwide (ACZ885, Placebo)

Completed
Has Results
  • Sickle Cell Anemia
  • ACZ885
  • Placebo
  • Atlanta, Georgia
  • +14 more
Oct 7, 2021

Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome, Recurrent Chronic Myelomonocytic Leukemia Trial in Houston

Recruiting
  • Chronic Myelomonocytic Leukemia
  • +5 more
  • Canakinumab
  • Houston, Texas
    M D Anderson Cancer Center
Dec 7, 2022

COVID-19, SARS-CoV 2 Trial in Weston, Cleveland (Canakinumab Injection 600mg, Canakinumab Injection 300mg, Placebos)

Completed
Has Results
  • COVID-19
  • SARS-CoV 2
  • Canakinumab Injection 600mg
  • +2 more
  • Weston, Florida
  • +1 more
Apr 13, 2021

NSCLC Trial in United States (Canakinumab, Durvalumab, Radiation therapy)

Recruiting
  • Non-small Cell Lung Cancer
  • Basking Ridge, New Jersey
  • +6 more
Aug 15, 2022

Abdominal Aortic Aneurysm (AAA) Trial in Worldwide (ACZ885, Placebo)

Terminated
Has Results
  • Abdominal Aortic Aneurysm (AAA)
  • ACZ885
  • Placebo
  • Charlottesville, Virginia
  • +8 more
Dec 9, 2020

MDS Trial in Worldwide (MBG453, NIS793, canakinumab)

Recruiting
  • Myelodysplastic Syndromes
  • Duarte, California
  • +14 more
Jan 23, 2023

Peripheral Artery Disease Trial in Germany, Jordan, United States (Canakinumab (ACZ885), Placebo)

Terminated
Has Results
  • Peripheral Artery Disease
  • Canakinumab (ACZ885)
  • Placebo
  • Phoenix, Arizona
  • +13 more
Dec 9, 2020

Mild Cognitive Impairment, Alzheimer Trial in Worldwide (Canakinumab, Placebo)

Recruiting
  • Mild Cognitive Impairment
  • Alzheimer Disease
  • Canakinumab
  • Placebo
  • Charlestown, Massachusetts
  • +11 more
Nov 11, 2022

Rheumatoid Arthritis Trial in Worldwide (Canakinumab)

Completed
Has Results
  • Rheumatoid Arthritis
  • Huntsville, Alabama
  • +50 more
Jun 17, 2021

Cytokine Release Syndrome in COVID-19-induced Pneumonia Trial (canakinumab)

No longer available
  • Cytokine Release Syndrome in COVID-19-induced Pneumonia
  • (no location specified)
Feb 1, 2021

Knee Osteoarthritis Trial in Worldwide (canakinumab, LNA043, Placebo to canakinumab)

Recruiting
  • Knee Osteoarthritis
  • canakinumab
  • +2 more
  • Clearwater, Florida
  • +19 more
Dec 14, 2022

Lung Carcinoma, Stage I Lung Cancer AJCC v8, Stage IA1 Lung Cancer AJCC v8 Trial in Houston (Canakinumab, Quality-of-Life

Recruiting
  • Lung Carcinoma
  • +12 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 17, 2021

Gouty Arthritis Trial in Worldwide (Canakinumab)

Completed
Has Results
  • Gouty Arthritis
  • Seattle, Washington
  • +44 more
Jun 10, 2021

NSCLC Trial in Worldwide (canakinumab, pembrolizumab)

Completed
  • Non-small Cell Lung Cancer
  • La Jolla, California
  • +28 more
Sep 27, 2022

Colorectal Cancer, Triple Negative Breast Cancer, NSCLC - Adenocarcinoma Trial in Worldwide (PDR001, ACZ885, CJM112)

Completed
  • Colorectal Cancer, Triple Negative Breast Cancer, NSCLC - Adenocarcinoma
  • PDR001
  • +4 more
  • Baltimore, Maryland
  • +22 more
Mar 15, 2022

Behcet Disease Trial in Istanbul (Canakinumab)

Completed
Has Results
  • Behcet Disease
  • Istanbul, Turkey
    Novartis Investigative Site
May 28, 2020

Cytokine Release Syndrome (CRS) in Patients With COVID-19-induced Pneumonia Trial in Worldwide (Canakinumab, Placebo)

Completed
Has Results
  • Cytokine Release Syndrome (CRS) in Patients With COVID-19-induced Pneumonia
  • Birmingham, Alabama
  • +38 more
Jan 21, 2022

Acute Gouty Arthritis Flares Trial in Worldwide (ACZ885, Triamcinolone acetonide 40 mg)

Completed
Has Results
  • Acute Gouty Arthritis Flares
  • ACZ885
  • Triamcinolone acetonide 40 mg
  • Anniston, Alabama
  • +55 more
Jun 17, 2021